Riskpilot← Back to searchSign inGet full accessBansal Group AB
ABActiveOrg 5591598544Backegårdsvägen 2Activities of head offices · NACE 7010Est. 20187 employees
Revenue 2024
SEK 6,5M
+72% vs 2023
EBITDA margin
18.6%
+19% vs 2023
Equity ratio
59.9%
Financial strength
Net profit 2024
SEK 2,8M
+125% vs 2023
| Revenue | SEK 6,5M | +72% |
| EBITDA | SEK 1,2M | +19% |
| Net profit | SEK 2,8M | +125% |
| Total assets | SEK 21,9M | +14% |
| Equity | SEK 13,1M | +28% |
| Employees | 7 | — |
Legal name
Bansal Group AB
Org number
5591598544
Legal form
Aktiebolag
NACE code
7010 · Activities of head offices
Founded
22 maj 2018
Share capital
SEK 50 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva holdingverksamhet samt därmed förenlig verksamhet.
Address
Backegårdsvägen 2
Email
dbansal@innz.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 707 | 1 829 | 2 779 | 3 745 | 6 457 |
| Staff expenses | — | — | −2 240 | −2 486 | −4 491 |
| EBITDA | 33 | 234 | 363 | 1 009 | 1 203 |
| Depreciation & amort. | −0 | −0 | −5 | −3 | — |
| EBIT | 33 | 234 | 358 | 1 006 | 1 203 |
| Net financials | — | 9 393 | 2 183 | 1 056 | 2 756 |
| Profit before tax | 33 | 9 567 | 2 440 | 1 259 | 2 927 |
| Tax | −7 | −37 | −59 | −1 | −92 |
| Net profit | 26 | 9 530 | 2 381 | 1 259 | 2 836 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 041 | 12 840 | 19 476 | 19 120 | 21 874 |
| Equity | 88 | 9 618 | 8 999 | 10 257 | 13 093 |
| Long-term debt | 0 | 0 | 3 297 | 0 | — |
| Short-term debt | 5 952 | 3 222 | 7 084 | 8 767 | 8 537 |
| Total debt | 5 952 | 3 222 | 10 382 | 8 767 | 8 537 |
EBITDA margin
18.6%
This company
15.8%
Market median
+18% vs market
20202024
Equity ratio
59.9%
This company
38.2%
Market median
+57% vs market
20202024
Return on equity
21.7%
This company
18.4%
Market median
+18% vs market
20202024
Net profit margin
43.9%
This company
8.1%
Market median
+442% vs market
20202024
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20202024
Debt / equity
0.67×
This company
0.62×
Market median
+8% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BS Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bansal Group AB 
InnZ Medical ABBoard members of Bansal Group AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Stefan Carlsson | Audit | 0 companies |
| Dheeraj Bansal | Board of Directors | 0 companies |
| Monika Duchna | Deputy Board Member | 0 companies |